Patel Chem Specialities Ltd (PATELCHEM) is currently trading at 130.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Patel Chem Specialities Limited manufactures cellulose-based pharmaceutical excipients and specialty chemicals used in pharmaceutical, food and beverage, cosmetics, and industrial applications. Its portfolio includes sodium starch glycolate, croscarmellose sodium, cellulose derivatives, microcrystalline cellulose, and sodium monochloro acetate, serving diversified B2B customers across domestic and international markets. H1 FY27 revenue rose 25.07% year-on-year to ₹76.49 crore, indicating strong business growth. However, EBITDA increased 14.13% and PAT only 2.28%, showing that profitability lagged revenue expansion and that margin pressure remained a significant feature of the first half. The Talod expansion increased annual capacity from 720 MT to 4,500 MT following approximately ₹20 crore of capital expenditure. Trial production has begun, and commercial operations are expected shortly, creating a potentially important step-up in manufacturing scale and delivery capability. Capital deployment remains substantial, with capital work-in-progress rising 50.66% to ₹21.86 crore by September 2026. Borrowings also increased to ₹23.74 crore from ₹15.23 crore, suggesting that expansion is being supported by greater leverage alongside internal accruals and a cash balance of ₹31.04 crore. The company combines domestic and international B2B exposure with US-DMF, GMP, ISO 9001:2015, and US-FDA facility credentials. These certifications are important differentiators in regulated, quality-sensitive markets, although the supplied materials do not disclose customer concentration, export contribution, or market share.

Over the past 52 weeks, Patel Chem Specialities Ltd has traded between a low of ₹56.10 and a high of ₹167.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Patel Chem Specialities Ltd has a market capitalization of approximately 323.31. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Patel Chem Specialities Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 323.31 Cr, Patel Chem Specialities Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Patel Chem Specialities Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Patel Chem Specialities Ltd is 25.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Patel Chem reported revenue from operations of Rs 76.49 crore for H1 FY27, compared with Rs 61.16 crore in H1 FY26. The company reported year-on-year growth of 25.07% for the half year ended September 30, 2026.

The company announced it completed the Talod plant expansion, increasing annual capacity from 720 MT to 4,500 MT, with trial batches commenced and commercial production expected shortly.